Open AccessShould Graphic Warning Labels Proposed for Cigarette Packages Sold in the United States Mention the Food and Drug Administration?
Author(s) -
Mia Jovanova,
Chris Skurka,
Sahara Byrne,
Motasem Kalaji,
Amelia Greiner Safi,
Norman Porticella,
Alan Mathios,
Rosemary J. Avery,
Michael C. Dorf,
Jeff Niederdeppe
Publication year - 2020
Publication title -
nicotine and tobacco research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 113
eISSN - 1469-994X
pISSN - 1462-2203
DOI - 10.1093/ntr/ntaa142
Subject(s) - credibility , food and drug administration , tobacco control , source credibility , advertising , medicine , regulatory science , population , psychology , environmental health , internet privacy , business , public health , political science , nursing , computer science , law , pathology
Under the US Family Smoking Prevention and Tobacco Control Act, the US Food and Drug Administration (FDA) has the authority to implement graphic warning labels (GWLs) on cigarette packages. Neither the original labels proposed by the FDA nor the revised labels include a source to indicate sponsorship of the warnings. This study tests the potential impact of adding a sponsor to the content of GWLs.